WHITE PAPERS

The financial and operational systems behind a life sciences launch, across pharma, biologics, and cell and gene therapy.

A quality system and an ERP can both claim authority over the same lot of material. This paper covers who should own that decision, and how to connect the two systems so they never carry competing versions of it. Written for drug and medical device manufacturers operating under FDA and Health Canada.

This whitepaper highlights the financial complexity in behavioral health, where multiple payer types create challenges in billing, reporting, and compliance. It shows how NetSuite, configured by Archer Insights, unifies these processes into a single, audit-ready system—improving accuracy and visibility.

This guide explores the financial challenges in multi-location healthcare organizations, where disconnected systems create inefficiencies in billing, consolidation, and reporting. It shows how NetSuite, configured by Archer Insights, streamlines revenue cycle management, accelerates close, and enforces operational controls—improving accuracy, visibility, and scalability.

This whitepaper explores how procurement inefficiencies in healthcare—such as poor vendor management, lack of contract enforcement, and manual AP processes—lead to hidden overspend and financial risk. It shows how NetSuite, configured by Archer Insights, automates the procure-to-pay cycle to control spending before it happens and improve visibility and compliance.

Gross-to-Net (GTN) is one of the most underestimated risks in generic pharmaceutical finance. For emerging and mid-market generics companies, the question is rarely whether GTN matters; it is when complexity crosses the line from manageable to material. Oracle NetSuite is often positioned as either a complete GTN solution or entirely insufficient. Both views are wrong.

This whitepaper highlights the financial challenges behind fast-growing GLP-1 programs, including complex billing, high-cost inventory, and subscription-based revenue. It shows how NetSuite, configured by Archer Insights, unifies these processes to improve margin control and financial visibility.

The CDMO market is shifting from capacity to capability. Sponsors now expect partners who can reduce risk, move faster, and deliver with precision. As complexity grows, execution becomes the differentiator. CDMOs with connected systems and strong ERP foundations will be the ones that scale, stay compliant, and win.

Growth in nutraceutical manufacturing is exposing what’s broken. More SKUs, tighter margins, and rising compliance demands mean execution matters more than ever. The edge? ERP maturity.

In life sciences, the biggest risk isn’t the science, it’s the inability to scale. Delaying systems creates compliance gaps, launch delays, and lost value. The companies that win invest early in scalable ERP, turning infrastructure into a growth advantage instead of a bottleneck.